Stock Track | GRAIL, Inc. Stock Surges 11.68% on Optimistic Outlook for Cancer Screening Market

Stock Track

2025/02/21

GRAIL, Inc. (GRAL) saw its stock soar by 11.68% in the 24-hour period on Friday, driven by optimistic projections from analysts regarding the company's prospects in the cancer screening and early detection market.

The surge came after an article highlighted GRAIL as a top holding in the Innovator IB 50 fund (FFTY), an ETF focused on companies with strong profit growth, high margins, and high return on equity. Analysts are bullish on GRAIL's potential in the liquid biopsy market, which aims to detect cancer early through a simple blood test.

GRAIL's Galleri multi-cancer early detection test has shown promising results in clinical trials, and its recent partnerships with leading healthcare providers have fueled expectations for widespread adoption and revenue growth. Moreover, the company's Apollo Go robotaxi project is expected to break even in Wuhan in 2024 and be profitable in 2025 as the fleet expands in the city.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1117930013"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1117930013\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1117930013?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-21 14:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1117930013","market":"us","top_or_hot":-1,"title":"Stock Track | GRAIL, Inc. Stock Surges 11.68% on Optimistic Outlook for Cancer Screening Market","media":"Stock Track","content":"<p>GRAIL, Inc. (GRAL) saw its stock soar by 11.68% in the 24-hour period on Friday, driven by optimistic projections from analysts regarding the company's prospects in the cancer screening and early detection market.</p>\n\n<p>The surge came after an article highlighted GRAIL as a top holding in the Innovator IB 50 fund (FFTY), an ETF focused on companies with strong profit growth, high margins, and high return on equity. Analysts are bullish on GRAIL's potential in the liquid biopsy market, which aims to detect cancer early through a simple blood test.</p>\n\n<p>GRAIL's Galleri multi-cancer early detection test has shown promising results in clinical trials, and its recent partnerships with leading healthcare providers have fueled expectations for widespread adoption and revenue growth. Moreover, the company's Apollo Go robotaxi project is expected to break even in Wuhan in 2024 and be profitable in 2025 as the fleet expands in the city.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | GRAIL, Inc. Stock Surges 11.68% on Optimistic Outlook for Cancer Screening Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | GRAIL, Inc. Stock Surges 11.68% on Optimistic Outlook for Cancer Screening Market\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2025-02-21 14:52</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>GRAIL, Inc. (GRAL) saw its stock soar by 11.68% in the 24-hour period on Friday, driven by optimistic projections from analysts regarding the company's prospects in the cancer screening and early detection market.</p>\n\n<p>The surge came after an article highlighted GRAIL as a top holding in the Innovator IB 50 fund (FFTY), an ETF focused on companies with strong profit growth, high margins, and high return on equity. Analysts are bullish on GRAIL's potential in the liquid biopsy market, which aims to detect cancer early through a simple blood test.</p>\n\n<p>GRAIL's Galleri multi-cancer early detection test has shown promising results in clinical trials, and its recent partnerships with leading healthcare providers have fueled expectations for widespread adoption and revenue growth. Moreover, the company's Apollo Go robotaxi project is expected to break even in Wuhan in 2024 and be profitable in 2025 as the fleet expands in the city.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GRAL","symbol_name":"GRAIL, Inc.","start_time":0,"source_url":"","article_id":"1117930013","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1117930013","pubTimestamp":1740120751,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"GRAIL, Inc.  saw its stock soar by 11.68% in the 24-hour period on Friday, driven by optimistic projections from analysts regarding the company's prospects in the cancer screening and early detection market.The surge came after an article highlighted GRAIL as a top holding in the Innovator IB 50 fund , an ETF focused on companies with strong profit growth, high margins, and high return on equity. Analysts are bullish on GRAIL's potential in the liquid biopsy market, which aims to detect cancer e","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"GRAL":"GRAIL, Inc."},"translate_title":"股票追踪GRAIL，Inc.股价因癌症筛查市场前景乐观而飙升11.68%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GRAL":1},"content_text":"GRAIL, Inc. (GRAL) saw its stock soar by 11.68% in the 24-hour period on Friday, driven by optimistic projections from analysts regarding the company's prospects in the cancer screening and early detection market.\nThe surge came after an article highlighted GRAIL as a top holding in the Innovator IB 50 fund (FFTY), an ETF focused on companies with strong profit growth, high margins, and high return on equity. Analysts are bullish on GRAIL's potential in the liquid biopsy market, which aims to detect cancer early through a simple blood test.\nGRAIL's Galleri multi-cancer early detection test has shown promising results in clinical trials, and its recent partnerships with leading healthcare providers have fueled expectations for widespread adoption and revenue growth. Moreover, the company's Apollo Go robotaxi project is expected to break even in Wuhan in 2024 and be profitable in 2025 as the fleet expands in the city.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}